Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to assess the effectiveness of the Compound Sodium Alginate
Double Action Chewable Tablets compared to placebo on acidic reflux events into the esophagus
in patients diagnosed with Gastroesophageal Reflux Disease (GERD).